Growth inhibition of imatinib-resistant CML cells with the T315I mutation and hypoxia-adaptation by AV65 - a novel Wnt/β-catenin signaling inhibitor.
Kyoto University (京都大学) === 0048 === 新制・課程博士 === 博士(医科学) === 甲第16745号 === 医科博第30号 === 新制||医科||3(附属図書館) === 29420 === 京都大学大学院医学研究科医科学専攻 === (主査)教授 髙折 晃史, 教授 江藤 浩之, 教授 平家 俊男 === 学位規則第4条第1項該当...
Main Author: | Nagao, Rina |
---|---|
Other Authors: | 髙折, 晃史 |
Format: | Others |
Language: | English |
Published: |
Kyoto University
2012
|
Subjects: | |
Online Access: | http://hdl.handle.net/2433/157488 |
Similar Items
-
Activity of the multi-targeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL positive leukemic cells.
by: Tanaka, Ruriko
Published: (2011) -
SC29EK, a Peptide Fusion Inhibitor with Enhanced α-Helicity, Inhibits Replication of Human Immunodeficiency Virus Type 1 Mutants Resistant to Enfuvirtide
by: Naito, Takeshi
Published: (2012) -
γ-Secretase Inhibitors Prevent Overgrowth of Transplanted Neural Progenitors Derived from Human-Induced Pluripotent Stem Cells
by: Yoshikawa(Ogura), Aya
Published: (2013) -
Comparison of γδT cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid
by: Atif Saeed Mohammed Idrees
Published: (2013) -
Maturation, not initiation, is the major roadblock during reprogramming toward pluripotency from human fibroblasts
by: Tanabe, Koji
Published: (2014)